文献速递自身炎症与 IgG4 相关病

吸烟与IgG4相关性疾病风险的病例对照研究

The association of smoking with immunoglobulin G4-related disease: a case-control study.
PubMed 文献 · Rheumatology (Oxford) · 2021-01-01

该病例对照研究纳入234例IgG4相关性疾病(IgG4-RD)患者和1170名年龄、种族、性别匹配的对照,发现当前吸烟与IgG4-RD风险升高相关(OR 1.79,95%CI 1.08–2.95),女性及合并腹膜后纤维化或血清IgG4正常者关联更强。排除腹膜后纤维化病例后关联消失。当前吸烟是首个被识别的IgG4-RD可干预危险因素。

要点

  • 当前吸烟与IgG4-RD风险升高相关(OR 1.79,95%CI 1.08–2.95)。
  • 女性、合并腹膜后纤维化或IgG4正常者关联更强。
  • 排除腹膜后纤维化病例后当前吸烟与IgG4-RD无显著关联。

核心结论

  • 当前吸烟与IgG4-RD风险升高相关,尤其在女性、合并腹膜后纤维化或血清IgG4正常者中。
  • 当前吸烟是首个被识别的IgG4-RD可干预危险因素。

研究设计与样本

  • 病例对照研究,纳入Massachusetts General Hospital的234例IgG4-RD患者,按1:5与年龄、种族、性别匹配的对照(来自MGB Biobank)比较。
  • 采用条件logistic回归估计当前吸烟与IgG4-RD风险的关联。

主要发现

  • IgG4-RD患者中当前吸烟者25例(11%),对照中70例(6%),OR 1.79(95%CI 1.08–2.95)。
  • 女性患者中当前吸烟13例(14%),对照19例(4%),OR 3.79(95%CI 1.71–8.39)。
  • 合并腹膜后纤维化患者中当前吸烟13例(28%),对照13例(6%),OR 6.93(95%CI 2.78–17.26)。
  • 血清IgG4正常患者中当前吸烟21例(21%),对照21例(4%),OR 6.22(95%CI 3.09–12.49)。
  • 排除腹膜后纤维化病例后,当前吸烟与IgG4-RD无显著关联(12例[6%] vs 57例[6%],OR 0.95,95%CI 0.49–1.86)。

临床怎么用

  • 对IgG4-RD患者(尤其女性、合并腹膜后纤维化或血清IgG4正常者)应询问吸烟史并建议戒烟。
  • 当前吸烟可作为IgG4-RD风险咨询中可干预的危险因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the association between cigarette smoking and the odds of IgG4-related disease (IgG4-RD). METHODS: We performed a case-control study of patients with IgG4-RD compared in a 1:5 ratio with age-, race- and sex-matched controls. We included cases evaluated at the Massachusetts General Hospital, a hospital within the Mass General Brigham (MGB) System. Controls were identified from the MGB Biobank. Smoking status at the date of IgG4-RD diagnosis or corresponding index date was determined. Conditional logistic regression was used to estimate the association between cigarette smoking and the odds of having IgG4-RD. RESULTS: There were 234 IgG4-RD cases and 1170 controls. The mean age (59 years), sex (62% male) and race (75% white) were well balanced. IgG4-RD cases were more likely to be current smokers compared with controls [25 (11%) vs 70 (6%); odds ratio (OR) 1.79 (95% CI 1.08, 2.95)]. This association was strongest among female cases [13 (14%) vs 19 (4%);, OR 3.79 (95% CI 1.71, 8.39)] and those with retroperitoneal fibrosis [RPF; 13 (28%) vs 13 (6%);, OR 6.93 (95% CI 2.78, 17.26)] or normal IgG4 concentrations [21 (21%) vs 21 (4%); OR 6.22 (95% CI 3.09, 12.49)]. When RPF cases were excluded, there was no longer an association between current smoking and the odds of having IgG4-RD [12 (6%) vs 57 (6%); OR 0.95 (95% CI 0.49, 1.86)]. CONCLUSION: Being a current smoker is associated with greater odds of having IgG4-RD, especially among women and those with RPF or normal IgG4 concentrations. Current smoking is the first recognized modifiable risk factor for IgG4-RD.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Wallwork R, Perugino CA, Fu X, et al. The association of smoking with immunoglobulin G4-related disease: a case-control study. Rheumatology (Oxford). 2021. PMID: 33751033. doi:10.1093/rheumatology/keab172

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。